MRP1 expression constitutes a negative prognostic marker for early-stage breast cancer [26–29] and is predictive of poor response to chemotherapy and dismal survival in non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC) [30–34]. This evidence concerns the gene ABCC1 and small cell lung carcinoma.